CLINICAL_TRIALS
trial_result
· 2020-12-08
Clinical Trial Update: tTF-NGR Phase I Study [Phase 1]
Summary
Phase I trial update for tTF-NGR in malignant solid tumors and lymphomas has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospital Muenster | Conditions: Malignant Solid Tumors, Lymphomas | Phase 1 | Status: COMPLETED | Results posted: 2020-12-08